tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

MTNB Stock Latest News

Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update
Press ReleasesMatinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update
1d ago
MTNB
Matinas BioPharma to Webcast Conference Call to Discuss First Quarter 2024 Financial Results and Provide a Business Update on May 9, 2024
PremiumPress Releases
Matinas BioPharma to Webcast Conference Call to Discuss First Quarter 2024 Financial Results and Provide a Business Update on May 9, 2024
8d ago
MTNB
Matinas BioPharma announces publication of in vivo efficacy of MAT2203
PremiumThe Fly
Matinas BioPharma announces publication of in vivo efficacy of MAT2203
10d ago
MTNB
Matinas BioPharma initiated with a Buy at Alliance Global Partners
PremiumThe Fly
Matinas BioPharma initiated with a Buy at Alliance Global Partners
14d ago
MTNB
Matinas BioPharma’s Multi-Million Share Sale and Lock-Up Deal
PremiumCompany Announcements
Matinas BioPharma’s Multi-Million Share Sale and Lock-Up Deal
1M ago
8K
MTNB
Matinas BioPharma prices 33.33M shares at 30c in registered direct offering
PremiumThe FlyMatinas BioPharma prices 33.33M shares at 30c in registered direct offering
1M ago
MTNB
Matinas BioPharma Prices $10 Million Registered Direct Offering
PremiumPress Releases
Matinas BioPharma Prices $10 Million Registered Direct Offering
1M ago
MTNB
Matinas BioPharma Updates Presentation for Investor Outreach
PremiumCompany Announcements
Matinas BioPharma Updates Presentation for Investor Outreach
1M ago
8K
MTNB
Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update
PremiumPress Releases
Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update
1M ago
MTNB
Matinas announces in vivo safety data with oral LNC-doxetaxel formulation
PremiumThe Fly
Matinas announces in vivo safety data with oral LNC-doxetaxel formulation
2M ago
MTNB
Matinas BioPharma’s LNC Technology Promises Safer Chemotherapy
PremiumCompany Announcements
Matinas BioPharma’s LNC Technology Promises Safer Chemotherapy
2M ago
8K
MTNB
Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation
PremiumPress Releases
Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation
2M ago
MTNB
Matinas BioPharma’s MAT2203 Shows Promising Clinical Results
PremiumCompany AnnouncementsMatinas BioPharma’s MAT2203 Shows Promising Clinical Results
2M ago
8K
MTNB
Three Patients with Invasive Fusarium Infection in Matinas BioPharma’s Oral MAT2203 Compassionate/Expanded Use Access Program Achieve Complete Clinical Response
PremiumPress Releases
Three Patients with Invasive Fusarium Infection in Matinas BioPharma’s Oral MAT2203 Compassionate/Expanded Use Access Program Achieve Complete Clinical Response
2M ago
MTNB
Matinas BioPharma Regains Compliance with NYSE American Continued Listing Standards
PremiumPress Releases
Matinas BioPharma Regains Compliance with NYSE American Continued Listing Standards
2M ago
MTNB
Matinas BioPharma regains compliance with NYSE American
PremiumThe Fly
Matinas BioPharma regains compliance with NYSE American
2M ago
MTNB
Matinas BioPharma’s MAT2203 Shows Renal Improvement and Infection Recovery
PremiumCompany Announcements
Matinas BioPharma’s MAT2203 Shows Renal Improvement and Infection Recovery
2M ago
8K
MTNB
Matinas BioPharma provides update from Compassionate/EUA Program with MAT2203
PremiumThe Fly
Matinas BioPharma provides update from Compassionate/EUA Program with MAT2203
2M ago
MTNB
Matinas BioPharma Advances MAT2203 in Phase 3 Global Trial
PremiumCompany Announcements
Matinas BioPharma Advances MAT2203 in Phase 3 Global Trial
3M ago
8K
MTNB
Matinas BioPharma Successfully Reaches Agreement with FDA for a Single Phase 3 Registration Trial to Support an NDA for MAT2203 for the Treatment of Invasive Aspergillosis
PremiumPress ReleasesMatinas BioPharma Successfully Reaches Agreement with FDA for a Single Phase 3 Registration Trial to Support an NDA for MAT2203 for the Treatment of Invasive Aspergillosis
3M ago
MTNB
Matinas BioPharma reaches agreement with FDA for Phase 3 trial of MAT2203
PremiumThe Fly
Matinas BioPharma reaches agreement with FDA for Phase 3 trial of MAT2203
3M ago
MTNB
Matinas announces results from two LNC-formulated oligonucleotides studies
PremiumThe Fly
Matinas announces results from two LNC-formulated oligonucleotides studies
5M ago
MTNB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >